Multi-Center Evaluation of the VITEK MS v3.0 System for the Identification of Filamentous Fungi

Similar documents
Filamentous fungi MALDI-TOF identification

Evaluation of the VITEK MS MALDI-TOF MS System for Identification of Clinically. Relevant Filamentous Fungi. Carey-Ann D.

on November 12, 2018 by guest

MBT Filamentous Fungi Library. Innovation with Integrity. MALDI Biotyper MALDI-TOF

MALDI-TOF VITEK MS for the rapid and accurate. identification of dermatophytes on solid cultures

IDENTIFICATION OF FUNGAL PATHOGENS BY MALDI-TOF MASS SPECTROMETRY. Alex van Belkum Delhi - March 19, 2015

MALDI-TOF MS and Filamentous Fungal Identification: A Success Story?

Decision criteria for MALDI-TOF MS-based identification of filamentous fungi using commercial and in-house reference databases

About the Editor Gerri S. Hall, Ph.D.

Abstract. Introduction

MALDI-TOF Mass Spectrometry: A New Rapid ID Method in Clinical Microbiology

AUSTRALIAN ANTIFUNGAL SUSCEPTIBILITY DATA : PART 2 THE MOULDS ASPERGILLUS, SCEDOSPORIUM AND FUSARIUM.

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for the identification of beta-hemolytic streptococci

Insights into Antifungal Resistance & Newer (Other) Moulds

A MALDI-TOF MS procedure for clinical dermatophyte species identification in the routine laboratory

Treatment of rare and emerging fungal infections. EFISG Educational Workshop 15 th ECCMID April 2, 2005, Copenhagen

Ana Espinel-Ingroff 1, Elizabeth Johnson 2, Hans Hockey 3 and Peter Troke 4 *

Inter-laboratory comparison of sample preparation methods, database expansion and

Hyaline Molds. Aspergillus clavatus. Aspergillus flavus. Aspergillus fumigatus. Aspergillus glaucus. Aspergillus nidulans. Aspergillus niger Complex

The Differentiation of Yeast and Yeast-Like Forms in Human Tissues. Introduction. Histochemical Stains Used to Detect Fungi. Histopathologic Diagnoses

MALDI-TOF mass spectrometry tools for microbial identification in archival document investigation

Epidemiology and Resistance in Aspergillus and other Moulds

Tandem MS in Microbiology. Chris Doern, PhD D(ABMM) UT Southwestern Medical Center Dallas, TX

Mycology Review. Background. Background. Specimen Collection. Calcofluor White. Methods. Yeasts. Moulds. Melissa B. Miller, Ph.D.

Comparison of Vitek MS and MALDI Biotyper for identification of Actinomycetaceae of

YOTL a procedure for making auxiliary mass spectrum datasets for clinical routine identification of yeasts using the on-target-lysis method

Accuracy of MALDI-TOF mass spectrometry for the identification of

Comparison of mechanical disruption techniques for the rapid inactivation of

OVERVIEW OF CURRENT IDENTIFICATION SYSTEMS AND DATABASES

Received 6 May 2010/Returned for modification 21 June 2010/Accepted 9 July 2010

New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance

Comparison of Heat Inactivation Method and Cell Disruption Protocols for Identification

Comparative In Vitro Antifungal Activity of Amphotericin B and Amphotericin B Methyl Ester

Agar block smear preparation: a novel method of slide preparation for preservation

Prevalence of Nondermatophytes in Clinically Diagnosed Taeniasis

Thermotolerant filamentous fungi in belgian hospitals: 15 years of survey

Fungi. Eucaryotic Rigid cell wall(chitin, glucan) Cell membrane ergosterol Unicellular, multicellular Classic fungus taxonomy:

Int.J.Curr.Microbiol.App.Sci (2016) 5(9):

A class IIa medical device intended for mild-to-moderate fungal nail infection PRODUCT MONOGRAPH

The MALDI Biotyper An In Vitro Diagnostic System (IVD) for Identification of Bacteria and Yeasts with a Global Reach

Bloodborne Pathogens. Introduction to Fungi. Next >> COURSE 2 MODULE 4

Identification of Yeasts. Medical Mycology Training Network 15 November 2018 Dr Tan Ai Ling Department of Microbiology, Singapore General Hospital

Histopathology Description:

Overview of Microbiology. James D. Dick, PhD Johns Hopkins University

on November 3, 2018 by guest

Mycology. BioV 400. Subcutaneous Mycoses. Ecological associations. Geographic distribution World-wide

, Aspergillus A. terreus. 4 Candida albicans. 2 Otomycosis. , Histoplasmosis Paracoccidiomycosis

ISHAM Symposium: S33: Ocular aspects of Fungal Infections Friday, 8 May 2015, ; MR101/102 Level 1

Antifungal Susceptibility Testing

1. Multiple choice (30 2 each); circle the number of the correct choice. b. Trichophyton schoenleinii is traditionally most associated with

Ramanath Karicheri 1, Beena Antony 2* Original Research Article. Abstract

Rapid Detection and Identification of Candidemia by Direct Blood Culturing on Solid

VPM 201: Veterinary Bacteriology and Mycology 23-24/11/2011 LABORATORY 11: MYCOLOGY

In Vitro Studies with R 51,211 (Itraconazole)

FUNGAL INFECTIONS AMONG DIABETIC FOOT ULCER- PATIENTS ATTENDING DIABETIC CLINIC IN KENYATTA NATIONAL HOSPITAL, KENYA

Antifungal Properties of Cranberry Juice

THE USE OF DNA TESTING IN MOULD INVESTIGATIONS ANN DORTE PØRNEKI, M.SC.

Laboratory Identification of Leptotrichia Species Isolated From Bacteremia Patients at a Single Institution

MALDI Sepsityper Kit

Trichophyton Microsporum Epidermophyton. dermatomycosis. Dematiaceous(pigmented fungi ) Dimorphic fungi Yeast and yeast like saprophyte

UK Standards for Microbiology Investigations

Archives of Infect Diseases & Therapy, 2017

TEPZZ Z9Z74_A_T EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION

ANA ESPINEL-INGROFF* Division of Infectious Diseases, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia

Direct identification of bacteria from positive anaerobic BacT/Alert blood cultures by. Contents Category: Diagnostics, typing and identification

Food Category. Aspergillus flavus, Penicillium roqueforti, Wallemia sebi

Introduction: PCR Air Sampling: November 12, Carrie E Tompkins Elementary School PCR Fungi Study:

Evaluation of an alternative slide culture technique for the morphological identification of fungal species

Medical Microbiology, University Hospital of Liège, Liège, Belgium

Appropriate utilization of the microbiology laboratory. 11 April 2013

Dermatophytes Dr. Hala Al Daghistani

Rapid identification and resistance assessment: The future is mass spectrometry

Medical Mycology. Dr. Hala Al Daghistani

Malaysian Journal of Microbiology

Comparative study of MALDI-TOF MS and VITEK 2 in bacteria identification

SEASONAL VARIATION. Determination of the periodic composition of the leaf surface mycojlora.

INVESTIGATION OF DERMATOLOGICAL SPECIMENS FOR SUPERFICIAL MYCOSES

MYCOTAXON CONSULTING LTD. 3 Rockwood Ave. Halifax, Nova Scotia Canada B3N 1X4 Phone: Fax:

Brief Communication Clinical Microbiology

J of Evolution of Med and Dent Sci/ eissn , pissn / Vol. 3/ Issue 29/July 21, 2014 Page 8263

MALDI-TOF mass spectrometry for direct bacterial identification

ARTICLE IN PRESS. Enferm Infecc Microbiol Clin. 2013;xxx(xx):xxx xxx.

Identification of Mycoplasma spp. using MALDI-TOF Mass Spectrometry. Aric McDaniel

Tween 40-based precipitate production observed on modified chromogenic agar and development of biological identification kit for Malassezia species

Bureau of Laboratory Quality Standards Page 1 of 21

Mycological Profile of Bronchial Wash Specimens in Patients with Lower Respiratory Tract Infections

1* 1. Vijaya S. Rajmane, Shivaji T. Mohite

SCIENCE CHINA Life Sciences

Epidemiology and ecology of fungal diseases

MONTGOMERY COUNTY COMMUNITY COLLEGE BIO 140 MYCOLOGY OUTLINE. 1. Type of cell. 2. Fungi may be unicellular or multicellular

FIS 2014 Abstracts Mycology. Poster No 0097

New insights in the diagnosis of Candida infections

BIODIVERSITY AND CONCENTRATION OF AIRBORNE FUNGI IN CHICKEN HOUSE

Epidemiology and Laboratory Diagnosis of Fungal Diseases

Evaluation of in Vitro Antifungal Activity of Ketoconazole and Griseofulvin

MARGARET V. POWERS-FLETCHER, 1 BRIAN A. KENDALL, 1,2 ALLEN T. GRIFFIN, 3 and KIMBERLY E. HANSON 1,2 1

Transcription:

JCM Accepted Manuscript Posted Online 5 November 207 J. Clin. Microbiol. doi:0.28/jcm.03537 Copyright 207 American Society for Microbiology. All Rights Reserved. MultiCenter Evaluation of the VITEK MS v3.0 System for the Identification of Filamentous Fungi 2 3 4 5 6 7 8 9 0 2 3 4 5 6 Jenna Rychert, #, E. Sue Slechta, Adam P. Barker 2, Edwin Miranda 3, N. Esther Babady 3, YiWei Tang 3, 5, Connie Gibas 4, Nathan Wiederhold 4, DeAnna Sutton 4, Kimberly E. Hanson 2 ARUP Laboratories, Salt Lake City, UT, USA; 2 University of Utah, Salt Lake City, UT, USA; 3 Memorial Sloan Kettering Cancer Center, New York, NY, USA; 4 University of Texas Health Science Center, San Antonio, San Antonio, TX, USA; 5 Weill Medical College of Cornell University, New York, NY, USA Running Head: Identification of Mold Using VITEK MS v3.0 #Address correspondence to Jenna Rychert, Jennifer.Rychert@aruplab.com Deceased.

7 Abstract 8 9 20 2 22 23 24 25 26 27 28 29 30 3 32 33 34 35 Invasive fungal infections are an important cause of morbidity and mortality affecting primarily immunocompromised patients. While fungal identification to the species level is critical to providing appropriate therapy, it can be slow, laborious, and often relies on subjective morphologic criteria. The use of MALDITOF mass spectrometry has the potential to speed up and improve the accuracy of identification. In this multicenter study, we evaluated the accuracy of the VITEK MS v3.0 system in identifying,60 clinical mold isolates as compared to identification by DNA sequence analysis and supported by morphologic and phenotypic testing. Among the 59 isolates representing organisms in the v3.0 database, 9% (n=387) were correctly identified to the species level. An additional 27 isolates (2%) were correctly identified to the genus level. Fifteen isolates were incorrectly identified, either due to a single incorrect identification (n=3) or multiple identifications from different genera (n=2). In those cases, when a single identification was provided that was not correct, the misidentification was within the same genus. The VITEK MS v3.0 was unable to identify 9 (6%) isolates, despite repeat testing. These isolates were distributed among all the genera. When considering all isolates tested, even those that were not represented in the database, the VITEK MS v3.0 provided a single correct identification 98% of the time. These findings demonstrate that the VITEK MS v3.0 system is highly accurate for the identification of common molds encountered in the clinical mycology laboratory. 36 37 2

38 Introduction 39 40 4 42 43 44 45 46 47 48 49 50 5 52 53 54 55 56 57 58 Species level identification is critical for the evaluation and management of fungal infections. Mold identification has traditionally been based on subjective assessments of the macroscopic and microscopic appearance of organisms grown in culture. This is problematic given that species that may be morphologically similar can be genetically distinct, pathologically different, and may have different antifungal susceptibility profiles. Furthermore, consistent and accurate results are dependent on highly skilled clinical mycologists that have undergone substantial training. DNA sequencing is widely accepted as the reference method for fungal identification. However, accurate specieslevel identification often requires sequencing of multiple gene targets, can be expensive, and may not be readily available in the routine clinical setting. Matrixassisted laser desorption ionization time of flight mass spectrometry (MALDITOF MS) has potential clinical utility for species level identification of molds, just as it does for bacteria and yeasts (6). Recent studies suggest that successful identification of molds using mass spectrometry depends on the availability of a diverse and wellcurated database (77). Unlike the previous version, the newest version (v3.0) of the database that is included with the VITEK MS system (biomérieux, Inc., Durham, NC) includes 79 medically relevant mold species. Each species is represented by 222 unique isolates with 75% represented by four or more isolates (D. Pincus, personal communication). Database spectra were generated by testing each isolate under several growth conditions, including several media types and multiple incubation times, using multiple instruments, and several different operators. The end result is a collection of 3

59 60 6 over 20 reference spectra per species. In the present study, we evaluated the accuracy of the VITEK MS v3.0 system for identification of clinically relevant molds in comparison to DNA sequence analysis supported by morphologic and phenotypic testing. 62 63 64 65 66 67 68 69 70 7 72 73 74 75 76 77 78 79 Results Clinical isolates. A total of,59 unique mold isolates, representing organisms that are included in the VITEK MS v3.0 database, were tested over the course of the study. These isolates included 26 genera and 5 species. As shown in Table, the VITEK MS v3.0 provided a single identification that was correct to the species level for,387 (9%) of the isolates tested. An additional 27 (2%) isolates were correctly identified at the genus level (Table 2). Correct genus level identifications were instances where the VITEK MS v3.0 reported multiple species within the same genus, and this matched the genus identification provided by the reference method. As shown in Table 3, 5 isolates were misidentified (%), either as a result of a single incorrect identification (3 isolates) or reporting of multiple genera (2 isolates). All single species incorrect identifications were accurate at the genus level. In addition, results with multiple genera always included the correct specieslevel identification. Given that sequencing cannot always discriminate between phylogenetically similar organisms, we verified that these reference results were accurate using maximum parsimony and Bayesian analyses (Supplemental Data). In all cases, the reference result provided in Table 3 was fully supported by these additional analyses. A total of 79 isolates (5%) had to undergo repeat testing in order to obtain the final result (Table 4). A minority of these (9 of 79, %) produced spectra of 4

80 8 82 83 84 85 86 87 88 89 90 9 92 93 94 95 96 97 insufficient quality, leading to the result of No Identification. For 50 of the isolates, a correct identification was made after respotting the original extract. The other 29 isolates required reextraction to get the correct identification. A result of No identification was obtained for 9 (6%) isolates despite repeat testing. Eightytwo isolates representing organisms not included in the VITEK MS v3.0 database were also tested (Table 5). In the majority of cases (60/82; 73%), the VITEK MS v3.0 gave a result of No identification. The remaining 27% (22 of 82) were provided with a single identification that was incorrect. These misidentifications represent % of the total isolates tested (22 of 60).The majority (20 of 22) of these misidentified isolates were still within the correct genus. Clinical isolate results by organism group Dimorphic fungi. The VITEK MS v3.0 accurately identified 4 of the 4 dimorphic fungi that were tested. This included 40 isolates of Blastomyces dermititidis, 38 isolates of Coccioides immitis/posadasii, 32 isolates of Histoplasma capsulatum, and 3 isolates of Sporothrix schenkii complex. Three Coccidiodes immitis/posadasii and one Histoplasma capsulatum had to be respotted after an initial result of No identification in order to obtain the final correct identification. 98 5

99 00 0 02 03 04 05 06 07 08 09 0 2 3 4 5 6 7 8 9 Mucorales. Of the 8 Mucorales isolates tested, 0 (86%) were accurately identified to the specieslevel. Accuracy was highest for Lictheimia corymbifera (29/3, 94%), followed closely by members of the Rhizopus microsporus complex (26/29, 90%). There was a single Rhizopus microsporus that was misidentified as Rhizopus arrhizus. Seven Mucor racemosus and three Rhizopus microsporus underwent repeat testing after an initial result of No identification. A correct identification was made by respotting the original extract in all of these cases. Sixteen Mucorales isolates (4%) could not be identified despite repeat testing; the majority of these were Mucor racemosus or Rhizopus arrhizus species complex. Aspergillus. Aspergillus species were one of the largest groups of organisms included in the study. The majority of Aspergillus isolates tested (305/329, 93%) were correctly identified to the species level. Twentythree (7%) Aspergillus isolates were not identified. Repeat testing was performed on 6 isolates that were initially not identified, including 7 that needed to be respotted and 9 that needed to be reextracted. The VITEK MS v3.0 was least accurate for obtaining a species level identification for A. versicolor. One A. versicolor isolate was identified at the genus level and an additional eight could not be identified, despite repeat testing. Dematiaceous fungi. A total of 325 dematiaceous fungi were tested; 295 (9%) of these were correctly identified to the specieslevel. Of note, all 4 Scedosporium apiospermum, 32 Scedosporium prolificans, and 3 Exophiala dermatitidis were correctly identified. Eleven of the dematiaceous fungal isolates required repeat testing due to a failure to be identified on the first 6

20 2 22 23 24 25 26 27 28 29 30 3 32 33 34 35 36 37 38 39 40 analysis. Five of these were correctly identified after respotting the initial extract and another five were correctly identified after spotting a new extract. There was one Scedosporium boydii (formerly Pseudallescheria boydii) isolate that was misidentified after repeat testing of a new extract as Scedosporium apiospermum. Note that these organisms were previously considered to be the sexual (teleomorph) and asexual (anamorph) forms of one another, respectively, but are now recognized as separate species (8). There was also a Cladophialophora bantiana isolate in which the VITEK MS v3.0 gave a split result of Cladophialophora bantiana and Candida colliculosa. In all, the system failed to identify 28 (9%) of the dematiaceous fungi tested. Of these, six (five E. rostratum and one C. spicifera) had spectra of insufficient quality on all repeat testing which led to the result of No Identification. Dermatophytes. The majority of the dermatophytes (246/29, 85%) were correctly identified to the specieslevel. Trichophyton species were particularly problematic, with 2 isolates incorrectly identified. Eleven of these were a single incorrect identification within the Trichophyton genus. The result for the remaining isolate was a split identification that included T. violaceum, Candida lambica, and Fusarium oxysporum complex. There were no Trichophyton isolates for which the VITEK MS v3.0 ultimately provided a result of No identification, however, 2 needed repeat testing in order to obtain the final correct result. There were seven Microsporum or Epidermophyton isolates that could not be identified by VITEK MS v3.0, with an additional 5 that required repeat testing after failing to be identified on the first analysis. E. floccosum was the only organism in this group for which repeat testing was the result of poor 7

4 42 quality spectra. For each of the three isolates of this organism that underwent repeat testing, lack of a quality spectra was the reason repeat testing was required. 43 44 45 46 47 48 49 50 5 52 53 54 55 56 57 58 Other Potential Pathogens. Among the other 36 potentially pathogenic molds tested, 299 (95%) were correctly identified to the species level. Among these were six isolates that were respotted and five isolates that were reextracted in order to get the final correct result after failing to be identified on the first analysis. No molds within this category were misidentified or identified only to the genus level. Seventeen of the isolates were not identified despite repeat testing. Challenge Set. In addition to the isolates obtained during the course of clinical work, a panel of 50 wellcharacterized isolates representing 6 genera and 27 species included in the VITEK MS v3.0 database were run at each of the three clinical laboratories. As shown in Table 6, 4 of the 50 (94%) challenge isolates were correctly identified to the species level. There were no misidentifications, but nine isolates could not be identified despite repeat testing. The VITEK MS v3.0 failed to identify two isolates in each of two laboratories and five isolates in the other laboratory. Specifically, an isolate of Rhizopus arrhizus was not identified at two of the three laboratories and an Aspergillus versicolor was not identified at any of the three laboratories. 59 8

60 6 62 63 64 65 66 67 68 69 70 7 72 73 74 75 76 77 78 79 80 Reproducibility. Reproducibility testing produced a single correct identification to the species level for 298 of the 300 (>99%) isolates in the reproducibility panel. In two instances, Purpureocillium lilacinum was not identified, once at site three and once at site one. There was also a single instance where Aspergillus fumigatus was not identified on the initial run at site three, but upon repeat testing of the same extract, the correct result to the species level was obtained. There were no misidentifications of any organism at any site. There also were no differences in organism identification by site, operator, reagent kit, or day. Given that the VITEK MS v3.0 failed to identify Purpureocillium lilacinum but no other organism, there may be organismspecific factors that contribute to a failure to identify a specific isolate. Discussion The US Food and Drug Administration (FDA) recently cleared the VITEK MS v3.0 system for the identification of 79 filamentous fungi. Identification of molds using this system requires sample preparation that is not necessary for the identification of bacteria and yeast. In particular, the sample is inactivated in ethanol and protein extraction is performed in a tube prior to deposition on the target slide. Testing can be performed within 28 days of visible growth on rapidly growing molds and within 525 days for slow growing molds. Thus, the VITEK MS v3.0 system, with its commercially available reagents, standardized SOP, and robust database that allows for flexibility in incubation time, should make identification of commonly encountered molds feasible for many clinical laboratories. 9

8 82 83 84 85 86 87 88 89 90 9 92 93 94 95 96 97 98 99 200 20 202 This study confirms the excellent accuracy and reproducibility of the VITEK MS v3.0 system for the identification of common molds to the genus or species level. Despite organism group specific limitations, when a single identification was provided it was correct 98% of the time. The system was especially good at identifying dimorphic fungi (00% accuracy), but somewhat less effective for dermatophytes, with only 85% of these isolates correctly identified to the species level. This was primarily due to a genus level identification or a misidentification between Trichophyton violaceum and Trichophyton rubrum and similar issues with Trichophyton species of Arthroderma benhamiae including T. verrucosum, T. interdigitale, and T. erinacei. In all these cases, the VITEK MS v3.0 result was a genetically similar species to the reference identification. Other MALDITOF MS studies have also noted difficulty in discriminating some Trichophyton species, especially T. violaceum and T. rubrum due to their high degree of homology (9, 20). This issue can sometimes be resolved by adding more spectral libraries for these organisms into the database; however, this is not always the case (7). Future database updates may want to take this into consideration. Relative to other groups, organisms in the order Mucorales were the most likely to produce a result of No identification even with repeat testing (4%). This was most pronounced for M. racemosus and R. arrhizus. While several studies have evaluated the accuracy of MALDITOF MS for identifying members of the Mucorales, these species are not well represented in the literature, so it is difficult to determine whether this is a common problem (8, 0,, 3, 223). Poorer performance for either the dermatophytes or the Mucorales is unlikely to be due to differences in the age of the culture at time of testing. While fungal protein profiles may change as incubation time 0

203 204 205 206 207 208 209 20 2 22 23 24 25 26 27 28 29 220 22 222 progresses, this has been accounted for in the VITEK MS v3.0 database. Several dematiaceous fungi could not be identified as a result of poor quality spectra. Initial studies suggested that darkly pigmented fungi may be difficult to identify by MALDITOF MS (24); however, more recent work has shown that this is not necessarily the case (8, 2527). Multiple studies have previously evaluated the accuracy of MALDITOF MS for identifying molds (7, 8, 07, 9, 20, 23, 28, 29). The strength of this study is the large number of organisms tested across a variety of clinical laboratories using a standardized procedure and instrumentation. A limitation is that the study primarily focused on molds more commonly encountered in the clinical mycology laboratory and those contained in the VITEK MS v3.0 database. Among the isolates that were tested that were not represented in the database, the majority was given the most appropriate result of No Identification. The misidentifications for organisms not represented in the database represent % of all of the isolates tested. Further, they were all correct at the genus level and the misidentification at the species level is unlikely to impact initial antifungal therapy. Performance of the system in clinical practice will ultimately depend on the epidemiology of organisms encountered in any individual clinical setting. For example, the spectrum of organisms identified in a reference setting or cancer center, may be more diverse than is seen in a community hospital. Using a customized database that is more comprehensive may make sense for some laboratories; however, creation of an expanded database with more rare organisms requires additional time, expertise, and quality control. 223

224 225 226 227 228 229 230 23 232 233 234 235 236 237 238 239 240 24 In summary, the VITEK MS v3.0 system is highly accurate for the identification of commonly encountered molds in the clinical mycology laboratory. With this technology, it may now be feasible for more clinical laboratories to accurately identify a range of filamentous fungi to the specieslevel. Materials and Methods Study Sites. VITEK MS v3.0 system test performance was evaluated at three clinical laboratories within the United States (ARUP Laboratories, Salt Lake City, UT; University of Texas Health Science Center, San Antonio, TX; and Memorial Sloan Kettering Cancer Center, New York, NY). Prior to initiation of testing, operators at each site were trained on the testing protocol, isolate and target slide preparation, and result review per the manufacturer s instructions. Prior to testing study samples, each operator was required to analyze a panel of five molds in duplicate (Aspergillus fumigatus, Fusarium proliferatum, Purpureocillium lilacinum, Lecythophora hoffmanii, and Penicillium chrysogenum). Testing could begin once they were able to achieve at least 90% agreement between duplicate samples and 95% correct identifications. This study was approved by the human subjects committees at the respective sites, when deemed necessary by their institutional review boards. 242 243 Mold Isolates. Each study site was responsible for testing approximately 0 clinical isolates per species of a predefined list of organisms (Table ), with preference given to fresh isolates 2

244 245 246 247 248 249 250 25 252 253 254 255 256 257 258 259 260 26 262 263 obtained during the course of clinical work. In the event that a site was unable to obtain 0 fresh isolates, additional frozen isolates obtained from a culture collection or provided by the study sponsor were permitted. In additional to the clinical isolates, each site also tested a challenge set consisting of 50 wellcharacterized strains. The identity of the organisms within the challenge set was blinded to the operators performing the testing. Cultures were incubated under standard conditions at 30 C and tested within 28 days of visible growth for rapidly growing molds or 525 days for slow growing molds. Cultures were grown on potato dextrose agar, Sabouraud dextrose agar, or Sabouraud dextrose agar with gentamicin and chloramphenicol. These culture conditions were identical to the conditions used to build the v3.0 Knowledgebase. Frozen isolates were required to undergo subculture twice prior to testing. Sample Preparation for MALDITOF Analysis. Sample preparation was performed according to the manufacturer s instructions using the VITEK MS Mould Reagent Kit (biomérieux, Durham, NC). Approximately cm 2 of mold was inactivated in 900 µl of 70% ethanol followed by centrifugation at 4,000 g for 2 minutes. Ethanol was removed and protein extraction was performed by resuspending the pellet in 40 µl of 70% formic acid and 40 µl of acetonitrile. After centrifugation again at 4,000 g for 2 min, µl of the supernatant was spotted on the target slide, allowed to dry, and overlaid with µl of a saturated solution of alphacyano4 3

264 265 hydroxycinnamic acid matrix in 50% acetonitrile plus 2.5% trifluoroacetic acid (VITEK MSCHCA; biomérieux, Inc.). 266 267 268 269 270 27 272 273 274 275 276 277 278 279 280 28 For instrument calibration, an Escherichia coli reference strain (ATCC 8739) was transferred to designated wells on the target slide using a.0 µl loop, overlaid with.0 µl of VITEK MSCHCA matrix, and air dried. Positive (Aspergillus brasiliensis; ATCC 6404) and negative (reagents alone) controls were analyzed on each day of testing. Organism Identification using the VITEK MS v3.0 System. The VITEK MS v3.0 system includes an OEM (original equipment manufacturer)labeled Shimadzu AXIMA Assurance mass spectrometer linked to a reference database as previously described (2). In those instances when a result of No identification was obtained, repeat testing of a single spot was performed using the same extract. If a result of No identification was obtained again, a new sample extract was prepared and tested on a single spot. If identification was still not made, a result of No Identification was used as the final result. In cases where multiple genera were reported, a new extract was prepared and tested on a single spot. The result obtained upon repeat testing was used as the final result. 282 283 Organism Identification by DNA Sequencing. All study isolates were sent to a centralized laboratory (Fungus Testing Laboratory, University of Texas Health Science Center, San Antonio, 4

284 285 286 287 288 289 290 29 292 293 294 295 296 297 298 299 300 30 TX) for DNA sequencebased identification combined with morphologic/phenotypic characteristics. DNA sequence analysis was performed after PCR amplification and sequencing of isolatespecific targets (ITS/ITS2 and D/D2 regions of rrna, tubulin, calmodulin, actin, glyceraldehyde3phosphate dehydrogenase, RNA polymerase II subunits RPB & RPB2, and/or translation elongation factor genes) (30). BLASTn analysis of the DNA sequences was conducted using publically available databases, including GenBank, CBS KNAW, and FusariumDB. DNA sequence identification results were confirmed by morphologic/phenotypic analysis. In the event of a discrepancy or lowdiscrimination result, or when discordant results were obtained using this method, supplemental sequencing of a different gene target and/or phenotypic testing was performed. Analysis. The VITEK MS v3.0 result was considered accurate to the species level if a single identification was given and it matched the identification obtained by sequencing. It was considered correct to the genus level if multiple identifications, all from the same genus, were reported and this matched the genus obtained by sequencing. It was considered incorrect, if a single identification was given that did not match (at some taxonomic level) the result obtained by sequencing or when multiple identifications of different genera were reported. 302 303 304 Reproducibility testing. Reproducibility testing was performed by two operators at each clinical laboratory. A panel of five organisms (Aspergillus fumigatus, Fusarium proliferatum, Purpureocillium lilacinum, Lecythophora hoffmannii, and Penicillium chrysogenum) was tested 5

305 306 307 308 309 30 3 32 33 34 35 36 37 38 39 320 32 in duplicate on two runs daily for five days. The identity of each organism was blinded to the operators. Testing was performed using three different lots of reagents. The position of each organism on the target slide was predetermined and tested sequentially on one slide and randomized on a second slide. Sample preparation, organism identification on the VITEK MS v3.0, and result analysis was performed as described above. Acknowledgements We thank Tracy McMillen, Pam Foster, Janet Hindler, Romney Humphries, Stephen Jenkins, Doris Ortez, Michael Pfaller, Tonya Snyder, Charles Stratton, and Susan WuButler for technical assistance and/or clinical isolate provision. This study was performed as part of an FDA trial of the VITEK MS v3.0 system and was funded by the device manufacturer (biomérieux, Inc., Durham, NC) under research agreements of SK203773 (Memorial Sloan Kettering Cancer Center). The analysis of the data presented herein was performed by the study authors without influence by the device manufacturer. This study was supported in part by an NIH/NCI Cancer Center Support Grant P30 (CA008748). 322 6

323 References 324 325 326 327 328 329 330 33 332 333 334 335 336 337 338 339 340 34 342 343 344. Richter SS, Sercia L, Branda JA, Burnham CA, Bythrow M, Ferraro MJ, Garner OB, Ginocchio CC, Jennemann R, Lewinski MA, Manji R, Mochon AB, Rychert JA, Westblade LF, Procop GW. 203. Identification of Enterobacteriaceae by matrixassisted laser desorption/ionization timeofflight mass spectrometry using the VITEK MS system. Eur J Clin Microbiol Infect Dis 32:57578. 2. Rychert J, Burnham CA, Bythrow M, Garner OB, Ginocchio CC, Jennemann R, Lewinski MA, Manji R, Mochon AB, Procop GW, Richter SS, Sercia L, Westblade LF, Ferraro MJ, Branda JA. 203. Multicenter evaluation of the Vitek MS matrixassisted laser desorption ionizationtime of flight mass spectrometry system for identification of Grampositive aerobic bacteria. J Clin Microbiol 5:2225223. 3. Westblade LF, Jennemann R, Branda JA, Bythrow M, Ferraro MJ, Garner OB, Ginocchio CC, Lewinski MA, Manji R, Mochon AB, Procop GW, Richter SS, Rychert JA, Sercia L, Burnham CA. 203. Multicenter study evaluating the Vitek MS system for identification of medically important yeasts. J Clin Microbiol 5:22672272. 4. Branda JA, Rychert J, Burnham CA, Bythrow M, Garner OB, Ginocchio CC, Jennemann R, Lewinski MA, Manji R, Mochon AB, Procop GW, Richter SS, Sercia LF, Westblade LF, Ferraro MJ. 204. Multicenter validation of the VITEK MS v2.0 MALDITOF mass spectrometry system for the identification of fastidious gramnegative bacteria. Diagn Microbiol Infect Dis 78:293. 5. Garner O, Mochon A, Branda J, Burnham CA, Bythrow M, Ferraro M, Ginocchio C, Jennemann R, Manji R, Procop GW, Richter S, Rychert J, Sercia L, Westblade L, 7

345 346 347 348 349 350 35 352 353 354 355 356 357 358 359 360 36 362 363 364 365 366 Lewinski M. 204. Multicentre evaluation of mass spectrometric identification of anaerobic bacteria using the VITEK(R) MS system. Clin Microbiol Infect 20:335339. 6. Manji R, Bythrow M, Branda JA, Burnham CA, Ferraro MJ, Garner OB, Jennemann R, Lewinski MA, Mochon AB, Procop GW, Richter SS, Rychert JA, Sercia L, Westblade LF, Ginocchio CC. 204. Multicenter evaluation of the VITEK(R) MS system for mass spectrometric identification of nonenterobacteriaceae Gramnegative bacilli. Eur J Clin Microbiol Infect Dis 33:337346. 7. Theel ES, Hall L, Mandrekar J, Wengenack NL. 20. Dermatophyte identification using matrixassisted laser desorption ionizationtime of flight mass spectrometry. J Clin Microbiol 49:4067407. 8. Lau AF, Drake SK, Calhoun LB, Henderson CM, Zelazny AM. 203. Development of a clinically comprehensive database and a simple procedure for identification of molds from solid media by matrixassisted laser desorption ionizationtime of flight mass spectrometry. J Clin Microbiol 5:828834. 9. L'Ollivier C, Cassagne C, Normand AC, Bouchara JP, ContetAudonneau N, Hendrickx M, Fourquet P, Coulibaly O, Piarroux R, Ranque S. 203. A MALDITOF MS procedure for clinical dermatophyte species identification in the routine laboratory. Med Mycol 5:73720. 0. Becker PT, de Bel A, Martiny D, Ranque S, Piarroux R, Cassagne C, Detandt M, Hendrickx M. 204. Identification of filamentous fungi isolates by MALDITOF mass spectrometry: clinical evaluation of an extended reference spectra library. Med Mycol 52:826834. 8

367 368 369 370 37 372 373 374 375 376 377 378 379 380 38 382 383 384 385 386 387. Ranque S, Normand AC, Cassagne C, Murat JB, Bourgeois N, Dalle F, GariToussaint M, Fourquet P, Hendrickx M, Piarroux R. 204. MALDITOF mass spectrometry identification of filamentous fungi in the clinical laboratory. Mycoses 57:3540. 2. Schulthess B, Ledermann R, Mouttet F, Zbinden A, Bloemberg GV, Bottger EC, Hombach M. 204. Use of the Bruker MALDI Biotyper for identification of molds in the clinical mycology laboratory. J Clin Microbiol 52:27972803. 3. Chen YS, Liu YH, Teng SH, Liao CH, Hung CC, Sheng WH, Teng LJ, Hsueh PR. 205. Evaluation of the matrixassisted laser desorption/ionization timeofflight mass spectrometry Bruker Biotyper for identification of Penicillium marneffei, Paecilomyces species, Fusarium solani, Rhizopus species, and Pseudallescheria boydii. Front Microbiol 6:679. 4. Cassagne C, Normand AC, L'Ollivier C, Ranque S, Piarroux R. 206. Performance of MALDITOF MS platforms for fungal identification. Mycoses 59:678690. 5. Normand AC, Cassagne C, Gautier M, Becker P, Ranque S, Hendrickx M, Piarroux R. 207. Decision criteria for MALDITOF MSbased identification of filamentous fungi using commercial and inhouse reference databases. BMC Microbiol 7:25. 6. Park JH, Shin JH, Choi MJ, Choi JU, Park YJ, Jang SJ, Won EJ, Kim SH, Kee SJ, Shin MG, Suh SP. 207. Evaluation of matrixassisted laser desorption/ionization timeoffight mass spectrometry for identification of 345 clinical isolates of Aspergillus species from Korean hospitals: comparison with molecular identification. Diagn Microbiol Infect Dis 87:283. 9

388 389 390 39 392 393 394 395 396 397 398 399 400 40 402 403 404 405 406 407 408 409 7. Sanguinetti M, Posteraro B. 207. Identification of Molds by MatrixAssisted Laser Desorption IonizationTime of Flight Mass Spectrometry. J Clin Microbiol 55:369379. 8. Gilgado F, Cano J, Gene J, Sutton DA, Guarro J. 2008. Molecular and phenotypic data supporting distinct species statuses for Scedosporium apiospermum and Pseudallescheria boydii and the proposed new species Scedosporium dehoogii. J Clin Microbiol 46:76677. 9. De Respinis S, Monnin V, Girard V, Welker M, Arsac M, Celliere B, Durand G, Bosshard PP, Farina C, Passera M, Van Belkum A, Petrini O, Tonolla M. 204. Matrixassisted laser desorption ionizationtime of flight (MALDITOF) mass spectrometry using the Vitek MS system for rapid and accurate identification of dermatophytes on solid cultures. J Clin Microbiol 52:42864292. 20. de Respinis S, Tonolla M, Pranghofer S, Petrini L, Petrini O, Bosshard PP. 203. Identification of dermatophytes by matrixassisted laser desorption/ionization timeofflight mass spectrometry. Med Mycol 5:5452. 2. De Carolis E, Posteraro B, LassFlorl C, Vella A, Florio AR, Torelli R, Girmenia C, Colozza C, Tortorano AM, Sanguinetti M, Fadda G. 202. Species identification of Aspergillus, Fusarium and Mucorales with direct surface analysis by matrixassisted laser desorption ionization timeofflight mass spectrometry. Clin Microbiol Infect 8:475484. 22. Dolatabadi S, Kolecka A, Versteeg M, de Hoog SG, Boekhout T. 205. Differentiation of clinically relevant Mucorales Rhizopus microsporus and R. arrhizus by matrixassisted laser desorption ionization timeofflight mass spectrometry (MALDITOF MS). J Med Microbiol 64:69470. 20

40 4 42 43 44 45 46 47 48 49 420 42 422 423 424 425 426 427 428 429 430 43 23. McMullen AR, Wallace MA, Pincus DH, Wilkey K, Burnham CA. 206. Evaluation of the Vitek MS MatrixAssisted Laser Desorption IonizationTime of Flight Mass Spectrometry System for Identification of Clinically Relevant Filamentous Fungi. J Clin Microbiol 54:20682073. 24. Buskirk AD, Hettick JM, Chipinda I, Law BF, Siegel PD, Slaven JE, Green BJ, Beezhold DH. 20. Fungal pigments inhibit the matrixassisted laser desorption/ionization timeofflight mass spectrometry analysis of darkly pigmented fungi. Anal Biochem 4:22 28. 25. Kondori N, Erhard M, WelinderOlsson C, Groenewald M, Verkley G, Moore ER. 205. Analyses of black fungi by matrixassisted laser desorption/ionization timeofflight mass spectrometry (MALDITOF MS): specieslevel identification of clinical isolates of Exophiala dermatitidis. FEMS Microbiol Lett 362:6. 26. OzhakBaysan B, Ogunc D, Dogen A, Ilkit M, de Hoog GS. 205. MALDITOF MSbased identification of black yeasts of the genus Exophiala. Med Mycol 53:347352. 27. Singh A, Singh PK, Kumar A, Chander J, Khanna G, Roy P, Meis JF, Chowdhary A. 207. Molecular and MatrixAssisted Laser Desorption IonizationTime of Flight Mass SpectrometryBased Characterization of Clinically Significant Melanized Fungi in India. J Clin Microbiol 55:09003. 28. Alshawa K, Beretti JL, Lacroix C, Feuilhade M, Dauphin B, Quesne G, Hassouni N, Nassif X, Bougnoux ME. 202. Successful identification of clinical dermatophyte and Neoscytalidium species by matrixassisted laser desorption ionizationtime of flight mass spectrometry. J Clin Microbiol 50:2277228. 2

432 433 434 435 436 437 438 439 440 29. Nenoff P, Erhard M, Simon JC, Muylowa GK, Herrmann J, Rataj W, Graser Y. 203. MALDITOF mass spectrometry a rapid method for the identification of dermatophyte species. Med Mycol 5:724. 30. White TJ, T. Bruns, S. Lee, and J. W. Taylor 990. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics., p 35322 In Innis MA, D. H. Gelfand, J. J. Sninsky, and T. J. White (ed), PCR Protocols: A Guide to Methods and Applications. Academic Press, Inc., New York. Downloaded from http://jcm.asm.org/ on December 3, 208 by guest 22

Dematiaceous (n=325) Dermatophytes (n=29) Dimorphs (n=4) Mucorales (n=8) 44 Tables 442 443 Table. Accuracy of VITEK MS v3.0 Compared to Sequencing for Clinical Isolates Included in the Database Reference Identification Mucor racemosus complex (n=30) Rhizopus arrhizus complex (n=28) Rhizopus microsporus complex (n=29) Lichtheimia corymbifera (n=3) Correct to Species 24 (80) 22 (79) 26 (90) 29 (94) VITEK MS Identification (%) Correct to Genus Incorrect Results (3) No ID 6 (20) 6 (2) 2 (7) 2 (6) Total 0 (86) (<) 6 (4) Blastomyces dermatitidis (n=40) Coccidioides immitis/posadasii (n=38) Histoplasma capsulatum (n=32) Sporothrix schenckii complex (n=3) 40 (00) 38 (00) 32 (00) 3 (00) Total 4 (00) Arthroderma benhamiae (n=) Microsporum audouinii (n=33) Microsporum canis (n=3) Microsporum gypseum (n=35) Epidermophyton floccosum (n=3) Trichophyton mentagrophytes complex Trichophyton interdigitale (n=30) Trichophyton rubrum (n=3) Trichophyton tonsurans (n=33) Trichophyton verrucosum (n=3) Trichophyton violaceum (n=34) (n=) (00) 30 (9) 30 (97) 32 (9) 30 (97) (00) 29 (97) 3 (00) 30 (9) 8 (58) 4 (4) (3) (3) (3) 9 (29) 4 (4) 2 (6) 4 (3) 6 (8) 2 (6) (3) 3 (9) 2 (3) Total 246 (85) 26 (9) 2 (4) 7 (2) Alternaria alternata (n=32) Curvularia hawaiiensis (n=26) Curvularia spicifera (n=35) Exserohilum rostratum (n=35) Exophiala dermatitidis (n=3) Exophiala xenobiotica (n=32) Scedosporium boydii (n=32) Scedosporium apiospermum (n=4) Scedosporium prolificans (n=32) Cladophialophora bantiana (n=29) 30 (94) 25 (96) 34(97) 9 (54) 3 (00) 25 (78) 30 (94) 4 (00) 32 (00) 28 (97) (3) (3) 2 (6) (4) 2 (3) 6 3 (46) 7 (22) (3) Total 295 (9) 2 (<) 28 (9) 23

Other potential pathogens (n=36) Aspergillus species (n=328) 444 445 446 447 448 Aspergillus brasiliensis (n=3) Aspergillus calidoustus (n=33) Aspergillus flavus/oryzae (n=33) Aspergillus fumigatus (n=32) Aspergillus lentulus (n=30) Aspergillus nidulans (n=33) Aspergillus niger complex (n=37) Aspergillus sydowii (n=30) Aspergillus terreus complex (n=34) Aspergillus unguis (4) Aspergillus versicolor (n=3) 29 (94) 29 (88) 33 (00) 32 (00) 30 (00) 32 (97) 32 (87) 30 (97) 32 (94) 4 (00) 22 (7) (3) 2 (7) 4 (2) (3) 5 (4) (3) 2 (6) 8 (26) Total 305 (93) (<) 23 (7) Fusarium oxysporum complex (n=3) Fusarium proliferatum (n=30) Fusarium solani complex (n=39) Paecilomyces variotii (n=30) Penicillium chrysogenum (n=30) Penicillium citrinum (n=) Rasamsonia argillacea (n=34) Acremonium sclerotigenum (n=30) Lecythophora hoffmannii (n=30) Sarocladium kiliense (n=30) Purpureocillium lilacinum (n=3) 30 (97) 30 (00) 33 (85) 30 (00) 30 (00) (00) 29 (85) 30 (00) 27 (90) 30 (00) 29 (94) (3) 6 (5) 5 (5) 3 (0) 2 (6) Total 299 (95) 7 (5) Total Molds (n=59) 387 (9) 27 (2) 5 () 9 (6) Not included in FDA claim 2 No identification due to spectra of insufficient quality on all repeat testing 3 For five of 6 isolates, no identification due to spectra of insufficient quality on all repeat testing 24

449 Table 2. Correct Identifications to the Genus Level for Clinical Isolates Included in the v3.0 Database 450 45 452 453 Reference Result VITEK MS Result (number of results) Aspergillus versicolor Aspergillus versicolor, Aspergillus sydowii () Microsporum audouinii Microsporum canis, Microsporum audouinii () Trichophyton interdigitale Trichophyton tonsurans, Trichophyton interdigitale () Trichophyton tonsurans Trichophyton tonsurans, Trichophyton interdigitale () Trichophyton verrucosum Trichophyton verrucosum, Trichophyton erinacei (5) Trichophyton verrucosum, Trichophyton erinacei, Arthroderma benhamiae () Trichophyton verrucosum, Arthroderma benhamiae (2) Trichophyton erinacei, Arthroderma benhamiae () Trichophyton violaceum Trichophyton rubrum, Trichophyton violaceum (4) Arthroderma benhamiae is the telemorph of Trichophyton mentagrophytes Downloaded from http://jcm.asm.org/ on December 3, 208 by guest 25

Multiple Genera Single Identification 454 Table 3. Incorrect Identifications for Clinical Isolates Included in the v3.0 Database Reference Identification VITEK MS Identification (number of results) Rhizopus microsporus Rhizopus arrhizus () 455 456 457 458 459 460 Trichophyton tonsurans Trichophyton interdigitale (2) Trichophyton verrucosum Trichophyton interdigitale (3) Trichophyton verrucosum Trichophyton erinacei () Trichophyton violaceum Trichophyton rubrum (5) Scedosporium boydii 2 Scedosporium apiospermum () Cladophialophora bantiana Cladophialophora bantiana, Candida colliculosa () Trichophyton violaceum Trichophyton violaceum, Candida lambica, Fusarium oxysporum complex () For additional analysis regarding the reference identification, see Supplemental Data. 2 The anamorph of Scedosporium apiospermum was previously named Pseudallescheria boydii, but it is now considered a separate species. 26

Other potential pathogens (n=36) Aspergillus species (n=328) Dematiaceous (n=325) Dermatophytes (n=29) Dimorphs (n=4) Mucorales (n=8) 46 Table 4. Results of Repeat Testing Reference Identification Respot Correct ID VITEK MS Identification (%) Reextract Correct ID Reextract MisID Mucor racemosus complex (n=30) Rhizopus microsporus complex (29) 7 (23) 3 (0) Total 0 (8) Coccidioides immitis/posadasii (n=38) Histoplasma capsulatum (n=32) 3 (8) (3) Total 4 (3) Epidermophyton floccosum (n=3) Microsporum audouinii (n=33) Microsporum canis (n=3) Microsporum gypseum (n=35) Trichophyton interdigitale (n=30) Trichophyton rubrum (n=3) Trichophyton verrucosum (n=3) Trichophyton violaceum (n=34) Total 8 (6) 9 (3) Alternaria alternata (n=32) Curvularia hawaiiensis (n=26) Exophiala dermatitidis (n=3) Exserohilum rostratum (n=35) Scedosporium boydii (n=32) Scedosporium apiospermum (n=4) 7 3 2 3 2 2 Total 5 (2) 5 (2) (<) Aspergillus calidoustus (n=33) Aspergillus flavus/oryzae (n=33) Aspergillus nidulans (n=33) Aspergillus niger complex (n=37) Aspergillus sydowii (n=30) Aspergillus terreus complex (n=34) Aspergillus versicolor (n=3) Total 7 (2) 9 (3) Fusarium solani complex (n=35) Lecythophora hoffmannii (n=30) Paecilomyces variotii (n=30) Penicillium chrysogenum (n=30) Purpureocillium lilacinum (n=3) Rasamsonia argillacea (n=34) Sarocladium kiliense (n=30) Total 6 (2) 5 (2) 2 2 2 5 2 0 2 2 2 2 462 Total Molds (n=59) 50 (3) 28 (2) () 27

No Identification (n=60) Incorrect Identification (n=22) 463 Table 5. Organisms not included in the v3.0 Database 464 465 466 VITEK MS Identification Reference Identification (number of results) Aspergillus flavus/oryzae Aspergillus nomius () Aspergillus nidulans Aspergillus delacroxii (3) Aspergillus quadrilineatus (3) Emericella variecolor () Aspergillus versicolor Aspergillus amoenus (2) Aspergillus fructus () Candida kefyr/parapsilosis Cladophialophora boppii () Curvularia hawaiiensis Curvularia senegalensis () Curvularia spicifera Curvularia lunata () Curvularia pseudolunata () Fusarium chlamydosporum complex Fusarium incarnatumequiseti species complex () Fusarium oxysporum complex Fusarium nygamai () Fusarium proliferatum Fusarium fujikuroi (2) Mucor velutinosus Mucor circinelloides f. janssenii () Penicillium chrysogenum Penicillium rubens (2) No Identification Alternaria species () Aspergillus creber (2), Aspergillus jensenii (5), Aspergillus nomius (), Aspergillus section usti (), Aspergillus striatus/cleistominutus (), Aspergillus tabacinus (), Aspergillus tamarii () Chaetomium species () Cladophialophora carrionii (), Cladophialophora minourae (2) Cladosporium cladosporioides (), Cladosporium halotolerans (), Cladosporium sphaerospermum () Coprinellus xanthothrix () Curvularia aeria (2), Curvularia hominis (2), Curvularia lunata (), Curvularia pseudolunata (2), Curvularia species () Exophiala bergeri (), Exophiala oligosperma () Fusarium brachygibbosum (), Fusarium dimerum (2), Fusarium incarnatumequiseti species complex (), Fusarium lactis (), Fusarium lichenicola (), Fusarium sp. in Fusarium fujikuroi spp. Complex (), Fusarium sublutinans (), Fusarium verticillioides () Lichtheimia ramose (3), Lichtheimia ramose/corymbifera (2) Mucor circinelloides (), Mucor plumbeus () Paecilomyces formosus (2) Penicillium copticola (), Penicillium crustosum (2), Penicillium decumbens (), Penicillium janthinellum (), Penicillium paneum (), Penicillium polonicum (), Penicillium sizovae () Rhinocladiella similis () Sarocladium bifurcatum () Trichophyton soudanense () 28

467 468 Table 6. Accuracy of VITEK MS v3.0 Compared to Sequencing for the Challenge Set 469 470 VITEK MS Identification (%) Reference Identification Correct to Species Correct to Genus Incorrect No ID Alternaria alternata (n=3) 3 (00%) Aspergillus flavus/oryzae (n=2) 2 (00%) Aspergillus fumigatus (n=9) 9 (00%) Aspergillus lentulus (n=3) 3 (00%) Aspergillus nidulans (n=3) 3 (00%) Aspergillus niger complex (n=3) 3 (00%) Aspergillus sydowii (n=6) 6 (00%) Aspergillus terreus complex (n=6) 6 (00%) Aspergillus versicolor (n=6) 2 (33%) 4 (67%) Curvularia spicifera (n=3) 3 (00%) Epidermophyton floccosum (n=3) 3 (00%) Exophiala xenobiotica (n=3) 3 (00%) Fusarium oxysporum complex (n=9) 9 (00%) Fusarium solani complex (n=6) 6 (00%) Lecythophora hoffmannii (n=3) 3 (00%) Lichtheimia corymbifera (n=3) 3 (00%) Paecilomyces variotii complex (n=6) 6 (00%) Penicillium chrysogenum (n=2) 2 (00%) Purpureocillium lilacinum (n=6) 5 (83%) (7%) Rhizopus arrhizus complex (n=6) 3 (50%) 3 (50%) Rhizopus microsporus complex (n=3) 2 (66%) (33%) Sarocladium kiliense (n=3) 3 (00%) Scedosporium apiospermum (n=6) 6 (00%) Scedosporium boydii (n=6) 6 (00%) Scedosporium prolificans (n=3) 3 (00%) Trichophyton interdigitale (n=6) 6 (00%) Trichophyton rubrum (n=3) 3 (00%) Total in Challenge Set (n=50) 4 (94%) 9 (6%) 29